Related Experiment Video
Updated: Aug 13, 2025
15:41
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
Published on: October 15, 2013
15.0K
Advances in Microfluidics for Single Red Blood Cell Analysis
Georgii V Grigorev1,2,3, Alexander V Lebedev4, Xiaohao Wang5
1Data Science and Information Technology Research Center, Tsinghua Berkeley Shenzhen Institute, Tsinghua University, Shenzhen 518055, China.
Biosensors
|January 21, 2023
Summary
Microfluidic chips enable precise analysis of single red blood cells (RBCs) for diverse applications. This review covers advanced techniques and clinical uses, highlighting future prospects in RBC research.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Hematology
Background:
- Microfluidic technology offers advanced capabilities for studying individual red blood cells (RBCs).
- Applications span industrial and academic research, including lab-on-a-chip and organ-on-a-chip systems.
- Single RBC analysis is crucial for understanding various diseases and developing new diagnostics.
Purpose of the Study:
- To provide a comprehensive review of microfluidic techniques for single RBC analysis.
- To discuss recent advances in microfluidic platforms, sensors, and trapping methods.
- To explore the clinical implications and future directions of microfluidics in RBC-related research.
Main Methods:
- Review of current literature on microfluidic devices for RBC studies.
- Analysis of integrated sensors and microfluidic platforms for microscopic, tomographic, and spectroscopic analyses.
- Examination of various trapping arrays and manipulation techniques (e.g., dielectrophoresis, acoustics, optics).
Main Results:
- Microfluidics enables detailed analysis of single RBCs, including their physical and chemical properties.
- Various microfluidic techniques (e.g., bifurcating channels, dielectrophoresis, agglutination studies) are effective for RBC manipulation and analysis.
- Clinical applications include diagnostics for cancer, sepsis, prenatal testing, and Sickle Cell disease.
Conclusions:
- Microfluidic platforms offer significant potential for advancing single RBC studies and clinical diagnostics.
- Continued development in microfluidics, sensing, and organ-on-a-chip technologies will drive innovation in hematology and drug discovery.
- Addressing current limitations will pave the way for more sophisticated applications in personalized medicine.
